Cargando…
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer—A GEICO Study
SIMPLE SUMMARY: The response of high-grade serous ovarian cancer (HGSOC) to DNA-damaging agents largely depends on tumor genomic instability (GI), a phenomenon that affects the entire genome. Nowadays, surrogate biomarkers of this phenomenon, such as BRCA-gene mutations, are used in clinical practic...
Autores principales: | Fernández-Serra, Antonio, López-Reig, Raquel, Márquez, Raúl, Gallego, Alejandro, de Sande, Luís Miguel, Yubero, Alfonso, Pérez-Segura, Cristina, Ramchandani-Vaswani, Avinash, Barretina-Ginesta, María Pilar, Mendizábal, Elsa, Esteban, Carmen, Gálvez, Fernando, Sánchez-Heras, Ana Beatriz, Guerra-Alía, Eva María, Gaba, Lydia, Quindós, María, Palacio, Isabel, Alarcón, Jesús, Oaknin, Ana, Aliaga, Jessica, Ramírez-Calvo, Marta, García-Casado, Zaida, Romero, Ignacio, López-Guerrero, José Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252660/ https://www.ncbi.nlm.nih.gov/pubmed/37296992 http://dx.doi.org/10.3390/cancers15113030 |
Ejemplares similares
-
SEOM-GEICO clinical guidelines on endometrial cancer (2021)
por: Barretina-Ginesta, María Pilar, et al.
Publicado: (2022) -
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
por: Garcia-Casado, Zaida, et al.
Publicado: (2022) -
Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)
por: Rubio, María Jesús, et al.
Publicado: (2020) -
From Scarface to Scarlett : American films in the 1930s /
por: Dooley, Roger Burke, 1920-
Publicado: (1981) -
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study
por: Yubero, Alfonso, et al.
Publicado: (2022)